Hedge Fund - VenBio Select Advisor
Madrigal Pharmaceuticals Inc. ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $437,050,905 | 6.03% | 1,888,888 | $ |
| 2 | 2023 - Q3 (2023-09-30) | $227,092,200 | 3.54% | 1,555,000 | $ |
| 3 | 2023 - Q2 (2023-06-30) | $349,999,881 | 4.74% | 1,515,151 | $ |
| 4 | 2023 - Q1 (2023-03-31) | $403,766,505 | 5.98% | 1,666,666 | $ |
| 5 | 2022 - Q4 (2022-12-31) | $481,815,000 | 7.2% | 1,660,000 | $ |
| 6 | 2022 - Q3 (2022-09-30) | $99,760,000 | 1.84% | 1,535,000 | $ |
| 7 | 2022 - Q2 (2022-06-30) | $109,875,000 | 2.17% | 1,535,000 | $ |
| 8 | 2022 - Q1 (2022-03-31) | $139,821,000 | 2.55% | 1,425,000 | $ |
| 9 | 2021 - Q4 (2021-12-31) | $120,755,000 | 2.05% | 1,425,000 | $ |
| 10 | 2021 - Q3 (2021-09-30) | $113,701,000 | 1.78% | 1,425,000 | $ |
| 11 | 2021 - Q2 (2021-06-30) | $138,809,000 | 2.41% | 1,425,000 | $ |
| 12 | 2021 - Q1 (2021-03-31) | $166,682,000 | 2.87% | 1,425,000 | $ |
| 13 | 2020 - Q4 (2020-12-31) | $136,183,000 | 2.34% | 1,225,000 | $ |
| 14 | 2020 - Q3 (2020-09-30) | $105,670,000 | 1.5% | 890,000 | $ |
| 15 | 2020 - Q2 (2020-06-30) | $39,638,000 | 0.78% | 350,000 | $ |
| 16 | 2020 - Q1 (2020-03-31) | $23,299,000 | 0.78% | 349,000 | $ |
| 17 | 2019 - Q4 (2019-12-31) | $31,797,000 | 0.93% | 349,000 | $ |
| 18 | 2019 - Q3 (2019-09-30) | $31,039,000 | 1.29% | 360,000 | $ |
| 19 | 2019 - Q2 (2019-06-30) | $37,732,000 | 1.3% | 360,000 | $ |
| 20 | 2019 - Q1 (2019-03-31) | $38,831,000 | 1.67% | 310,000 | $ |
| 21 | 2018 - Q4 (2018-12-31) | $25,362,000 | 1.51% | 225,000 | $ |
| 22 | 2018 - Q3 (2018-09-30) | $99,142,000 | 4.55% | 463,000 | $ |
| 23 | 2018 - Q2 (2018-06-30) | $136,918,000 | 5.27% | 489,536 | $ |
The displayed share prices are average quarterly stock market prices.